Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin

Gene-based approaches for protein replacement therapies have the potential to reduce the number of administrations. Our previous work demonstrated that expression could be enhanced and/or the applied voltage reduced by preheating the tissue prior to pulse administration. In the current study, we uti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chelsea Edelblute, Cathryn Mangiamele, Richard Heller
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/35b2e5e109234f19a494aeaecbd72376
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35b2e5e109234f19a494aeaecbd72376
record_format dspace
spelling oai:doaj.org-article:35b2e5e109234f19a494aeaecbd723762021-11-25T18:41:42ZModerate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin10.3390/pharmaceutics131119081999-4923https://doaj.org/article/35b2e5e109234f19a494aeaecbd723762021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1908https://doaj.org/toc/1999-4923Gene-based approaches for protein replacement therapies have the potential to reduce the number of administrations. Our previous work demonstrated that expression could be enhanced and/or the applied voltage reduced by preheating the tissue prior to pulse administration. In the current study, we utilized our 16-pin multi-electrode array (MEA) and incorporated nine optical fibers, connected to an infrared laser, between each set of four electrodes to heat the tissue to 43 °C. For proof of principle, a guinea pig model was used to test delivery of reporter genes. We observed that when the skin was preheated, it was possible to achieve the same expression levels as gene electrotransfer without preheating, but with a 23% reduction of applied voltage or a 50% reduction of pulse number. With respect to expression distribution, preheating allowed for delivery to the deep dermis and muscle. This suggested that this cutaneous delivery approach has the potential to achieve expression in the systemic circulation, thus this protocol was repeated using a plasmid encoding Human Factor IX. Elevated Factor IX serum protein levels were detected by ELISA up to 100 days post gene delivery. Further work will involve optimizing protein levels and scalability in an effort to reduce application frequency.Chelsea EdelbluteCathryn MangiameleRichard HellerMDPI AGarticleelectrotransfergene deliveryelectroporationgene therapymulti-electrode arrayFactor IXPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1908, p 1908 (2021)
institution DOAJ
collection DOAJ
language EN
topic electrotransfer
gene delivery
electroporation
gene therapy
multi-electrode array
Factor IX
Pharmacy and materia medica
RS1-441
spellingShingle electrotransfer
gene delivery
electroporation
gene therapy
multi-electrode array
Factor IX
Pharmacy and materia medica
RS1-441
Chelsea Edelblute
Cathryn Mangiamele
Richard Heller
Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin
description Gene-based approaches for protein replacement therapies have the potential to reduce the number of administrations. Our previous work demonstrated that expression could be enhanced and/or the applied voltage reduced by preheating the tissue prior to pulse administration. In the current study, we utilized our 16-pin multi-electrode array (MEA) and incorporated nine optical fibers, connected to an infrared laser, between each set of four electrodes to heat the tissue to 43 °C. For proof of principle, a guinea pig model was used to test delivery of reporter genes. We observed that when the skin was preheated, it was possible to achieve the same expression levels as gene electrotransfer without preheating, but with a 23% reduction of applied voltage or a 50% reduction of pulse number. With respect to expression distribution, preheating allowed for delivery to the deep dermis and muscle. This suggested that this cutaneous delivery approach has the potential to achieve expression in the systemic circulation, thus this protocol was repeated using a plasmid encoding Human Factor IX. Elevated Factor IX serum protein levels were detected by ELISA up to 100 days post gene delivery. Further work will involve optimizing protein levels and scalability in an effort to reduce application frequency.
format article
author Chelsea Edelblute
Cathryn Mangiamele
Richard Heller
author_facet Chelsea Edelblute
Cathryn Mangiamele
Richard Heller
author_sort Chelsea Edelblute
title Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin
title_short Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin
title_full Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin
title_fullStr Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin
title_full_unstemmed Moderate Heat-Assisted Gene Electrotransfer as a Potential Delivery Approach for Protein Replacement Therapy through the Skin
title_sort moderate heat-assisted gene electrotransfer as a potential delivery approach for protein replacement therapy through the skin
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/35b2e5e109234f19a494aeaecbd72376
work_keys_str_mv AT chelseaedelblute moderateheatassistedgeneelectrotransferasapotentialdeliveryapproachforproteinreplacementtherapythroughtheskin
AT cathrynmangiamele moderateheatassistedgeneelectrotransferasapotentialdeliveryapproachforproteinreplacementtherapythroughtheskin
AT richardheller moderateheatassistedgeneelectrotransferasapotentialdeliveryapproachforproteinreplacementtherapythroughtheskin
_version_ 1718410763652038656